A Phase 3, Non-Investigational Product, Multi Country Cohort Study to Describe the Long-Term Safety and Effectiveness of a Prior Single-Dose Treatment With Investigative Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Participants With Hemophil
2026-09-10
عنوان الدراسة
A Phase 3, Non-Investigational Product, Multi Country Cohort Study to Describe the Long-Term Safety and Effectiveness of a Prior Single-Dose Treatment With Investigative Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Participants With Hemophilia A or Hemophilia B, Respectively
داعم الدراسة
Pfizer Inc.
دواء الدراسة
Giroctocogene Fitelparvovec and Fidanacogene Elaparvovec
رقم بروتوكول الدراسة
C0371017
حالة الدراسة
Ongoing
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh),King Abdallah Medical City (Makkah)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.